![FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial | DAIC FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial | DAIC](http://www.dicardiology.com/sites/default/files/Farxiga_1.jpeg)
FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial | DAIC
![FDA Approves Farxiga For Adults With HF With Reduced Ejection Fraction - American College of Cardiology FDA Approves Farxiga For Adults With HF With Reduced Ejection Fraction - American College of Cardiology](https://www.acc.org//-/media/Non-Clinical/Images/2019/11/CARDIOLOGY/Farxiga-1200x800.jpg)
FDA Approves Farxiga For Adults With HF With Reduced Ejection Fraction - American College of Cardiology
![AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance | Fierce Pharma AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1619989374/Farxiga%2010mg.jpg?VersionId=dHWdb1WN.E.nqpjVWVnOqyBuZk7JIEKD)